Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already state readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false. The description adds substantial behavior beyond that: ambiguous matches assert nothing and return figi_candidates, unresolved identifiers appear in an 'unresolved' field, LEI/FIGI enrichment degrades gracefully, and the call cascades through multiple internal lookup endpoints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is quite long, but it is structured with clear sections (example queries, SUPPORTED TYPES, behavioral caveats) and front-loads the key directive 'Use FIRST.' Every sentence carries useful guidance, though the density makes it slightly harder to scan than ideal.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Even without an output schema, the description explains return behavior in detail: unresolved identifiers are listed, ambiguous name matches produce figi_candidates, identifiers are source-labelled, and enrichment sources degrade gracefully. For a tool with two parameters and complex multi-source behavior, the description is complete enough for an agent to call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, but the description goes well beyond the schema by explaining the exact semantics of 'value': pass the ENTITY NAME ONLY, never the full noun phrase, and illustrates with bond issuer examples. It also clarifies that 'type' restricts resolution to company or drug and gives expected input formats like ticker, CIK, ISIN, or name.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific verb and resource: it resolves a user-spoken NAME to canonical/official identifiers. It lists concrete example queries and supported types, and distinguishes itself from siblings by noting it supplies IDs that 'other tools require as input' and 'Use FIRST whenever you have a name but need an ID.'

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides an explicit trigger condition ('Use FIRST whenever you have a name but need an ID') and explains it replaces 2-3 manual lookups. It does not explicitly name alternatives or when-not-to-use conditions, but it does convey the primary use case strongly.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.1/5.0
Disambiguation4/5

Most tools have clearly distinct purposes, especially between Wordnik and Pipeworx domains. However, some overlap exists among data query tools (e.g., ask_pipeworx vs deep_research) and company lookups (entity_profile vs compare_entities), but descriptions are detailed enough to differentiate them in most cases.

Naming Consistency3/5

Naming conventions are mixed: some tools use snake_case (ai_visibility_check), others use descriptive phrases (ask_pipeworx_grounded), and some are single words (remember, recall). There is no uniform verb_noun pattern, though groups like polymarket_* and scan_* provide some consistency within their subsets.

Tool Count2/5

With 42 tools, the server is overloaded. It combines two distinct services (Wordnik dictionary and Pipeworx data) into one set, making it feel like two servers merged. Many tools are niche (e.g., hyphenation, random_words), increasing count without clear benefit. A split would improve coherence.

Completeness4/5

The Wordnik coverage is thorough (definitions, examples, pronunciation, frequency, etc.), and Pipeworx covers a wide range of data sources with tools for basic lookups, comparisons, research, and subscriptions. Minor gaps exist (e.g., no update/delete for Wordnik data), but overall the surface is comprehensive for the intended use.